(Reuters) - The approval comes a day after Boston Scientific said it resolved Food and Drug Administration concerns tied to its manufacturing plant for heart-rhythm devices, paving the way for the company to gain product approvals.
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment